2GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
3Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
4Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
1Perez- Pedrero M J, Sanchez - Casado M, Rodriguez- Vil- lar S. Nebulized colistin treatment of multi - resistant Acine- tobaeter baumannii pulmonary infection in critical ill patients [J]. Mecl Intensiva,2011,35(4) : 226.
2Rao U, Picciin A, Malone A, et al. Utility of bronchoalveo- lar lavage in the diagnosis of pulmonary infection in children with haematologieal malignancies[J]. IRISH Journal of Med- ical Science, 2013, 182(2): 177.
3Levesque E, Samuel D. Postliver Transplantation Pulmonary Complications: Is Modified Clinical Pulmonary Infection Score Applieable[J]. Transplantation, 2013, 95(7) : E43.
4Alvarez N, Otero O, Camaeho F, et al. Passive administra- tion of purified secretory IgA from human eolostrum induces protection against Mycobacterium tuberculosis in a murine model of progressive pulmonary mtmology, 2013, 14(1): S3.
5Falagas M E, Kasiakou S K. infection [ J ]. BMC Im Local administration of polymyxins into the respiratory tract for the prevention and treatment of pulmonary infections in patients without cystic fibrosis[J]. Infection, 2007, 35(1): 3.
7Ma F, Xu S, Liu X, et al. The microRNA miR - 29 controls innate and adaptive immune responses to intracallular bacterial infection by targeting interferon - γ[ J ]. Nat Immunol, 2011, 12(9): 861.
8Wang C, Yang C, Sun G, et al. Comparative miRNA ex- pression profiles in individuals with latent and active tubercu- losis[J]. PLoS One, 2011, 6(10): e25832.
